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ABSTRACT
The crystal structure of the non-self-complementary
dodecamer DNA duplex formed by d(CG[5BrC]ATAT-
TTGCG) and d(CGCAAATATGCG) has been solved to
2.3 Å resolution, together with that of its complex
with the tris-benzimidazole minor groove binding
ligand TRIBIZ. The inclusion of a bromine atom on
one strand in each structure enabled the possibility
of disorder to be discounted. The native structure
has an exceptional narrow minor groove, of 2.5–2.6 Å
in the central part of the A/T region, which is increased
in width by ~0.8 Å on drug binding. The ligand mol-
ecule binds in the central part of the sequence. The
benzimidazole subunits of the ligand participate in
six bifurcated hydrogen bonds with A:T base pair
edges, three to each DNA strand. The presence of a
pair of C-H…O hydrogen bonds has been deduced
from the close proximity of the pyrrolidine group of
the ligand to the TpA step in the sequence.
INTRODUCTION
The structural features of the interactions of non-covalent
minor groove-binding drugs and ligands (typified by netropsin,
distamycin, Hoechst 33258, berenil and pentamidine) with
DNA have been extensively studied crystallographically (see
for example 1–7), as well as by a range of other biophysical
methods (see for example 8,9). The crystal structures of these
drug–oligonucleotide complexes can be classified into two
categories. The first, and largest, comprises 1:1 duplex:drug
complexes (1–7). All except one (10) involve dodecanucleo-
tides, with the central sequence 5'-AATT, 5'-TTAA, 5'-
AAATTT or 5'-ATAT, where these A/T-selective drugs are
bound. The second, numerically smaller, category includes
netropsin, distamycin and synthetic polyamide ligands bound
to a variety of sequences, with the ligands bound as dimers in
the minor groove (11–14). All of the minor groove complexes
have self-complementary sequences.
Analysis of these structures (2), together with data from
NMR (15) and footprinting (16) studies, have shown that
minor groove width is a major determinant of drug binding to
particular sequences, together with hydrogen bonding to
specific base edges forming the minor groove floor. Several
sets of rules based on these factors have been devised (17–20)
which have enabled a variety of polyamides to be constructed
for the recognition of a wide range of desired sequences. It has
proved challenging to extend this recognition beyond a site
size of ~6 bp, although sequences in this size range can be very
effectively recognised by hairpin polyamide ligands, with
nanomolar binding affinities for target sequences in vitro
(21,22). Sequence specificity to regulatory DNA targets has
also been demonstrated in live cells (22,23).
The bis-benzimidazole ligand Hoechst 33258 (Fig. 1) and its
analogues interact in the minor groove in a manner analogous
to netropsin in that an identical arrangement of hydrogen
bonds (from the two benzimidazole groups) to A:T base pair
edges is formed (see for example 24–27). The benzimidazole
unit is thus a conformationally stable and appropriate platform
on which to build further DNA sequence recognition. We have
previously determined (28) the crystal structure of the tris-
benzimidazole ligand TRIBIZ (Fig. 1) bound to the self-
complementary duplex sequence d(CGCAAATTTGCG). This
structure showed that the ligand, which covers ~7.5 bp,
interacts with the minor groove edges of the four central A:T
base pairs by means of three sets of bifurcated hydrogen bonds.
Several significant changes were observed in the structure of
the oligonucleotide: minor groove width was narrowed and
numerous small changes in propeller and helical twist were
found. These latter indicated an unwinding of the central AT
region by ~15º in total, in order to achieve isohelical register of
base pair edges with the hydrogen bond donation from each
benzimidazole subunit. Studies on closely related tris-
benzimidazoles have confirmed that weak unwinding does
occur (29). These have also suggested that the DNA cleavage
mediated by DNA topoisomerase I and tris-benzimidazoles is
a direct consequence of their minor groove binding (30,31).
We report here the crystal structure analysis of TRIBIZ
bound to the sequence d(CGCATATTTGCG)·d(CGCAA-
ATATGCG), as well as that of this native duplex. This is the
first report of a minor groove ligand complex involving a non-
self-complementary duplex. It was chosen in order to: (i) extend
our knowledge of benzimidazole minor groove recognition to
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a mixed alternating/non-alternating run of A:T base pairs;
(ii) examine the role that sequence (and structural) asymmetry
play in the recognition process. Few non-self-complementary
DNA crystal structures have been reported to date (notably refs
32–34), with disorder being a common problem. In order to
unequivocally determine whether the present structures are
similarly affected, a 5-brominated cytosine was incorporated at
position three on just one strand, i.e. d(CG[5BrC]ATATTTGCG).
It was judged that the position of the bromine atom in the major
groove would not affect minor groove ligand binding in any way.
MATERIALS AND METHODS
The two DNA dodecamers d(CG[5BrC]ATATTTGCG) and its
complementary sequence d(CGCAAATATGCG) were purchased
from the Oswel DNA Service (University of Southampton,
UK). The two nucleotides were mixed in equimolar amounts
and annealed before use at 80°C for 10 min.
Crystallisation and data collection
The hanging drop method was used for crystal growth. Both
native and drug complex crystals were grown at 13°C. Droplets
contained 1 µl of 75 mM MgCl2, 1.5 µl of 15 mM spermine,
2 µl of 3 mM duplex and 2 µl MPD (25% w/v for the native
and 30% for the drug complex), in 40 mM sodium cacodylate
buffer, pH 6.5, equilibrated against a 35% w/v MPD reservoir.
An aliquot of 2 µl of 3 mM TRIBIZ, as the hydrochloride salt,
was added for the drug complex. In both cases, prismatic
crystals grew in 3 weeks. Those co-crystallised with TRIBIZ
were bright yellow.
Diffraction data were collected on a Rigaku RAXIS-4 image
plate detector with CuKα radiation from a Rigaku RU200
rotating anode generator (100 mA, 50 kV) and a Yale focussing
mirror system, set at a crystal to detector distance of 100 cm.
Crystals were flash frozen before use and maintained at –173°C
using an Oxford Cryostream (Oxford Cryosystems). No additional
cryoprotectant was required. One crystal was used for each
structure and 100 frames of intensity data were collected using
a 1.5º oscillation angle, resulting in the collection of ~16 000
reflections per structure. Data processing was carried out using
the DENZO and SCALEPACK packages (35). A total of 3508
unique reflections to 2.2 Å were observed for the native struc-
ture (94.1% of the possible reflections were statistically signif-
icant to this resolution). Cell dimensions were: a = 25.19 Å, b
= 40.58 Å, c = 66.01 Å, space group P212121, Rmerge(I) = 6.7%
for all data to 2.2 Å. A total of 3281 unique reflections to 2.2 Å
were observed for the TRIBIZ complex (87.7% of the possible
reflections to this resolution). Cell dimensions were: a = 25.50 Å,
b = 40.42 Å, c = 65.55 Å, space group P212121, Rmerge(I) = 5.0%
for all data to 2.2 Å.
Structure determination and refinement
The atomic coordinates for the DNA from the d(CGCAA-
ATTTGCG)–distamycin complex (36) were used as the starting
point for molecular replacement solution of both structures. It
was assumed that both structures are isomorphous with this
structure and with other dodecanucleotide structures.
The native structure refinement was initiated with the model
as a rigid body, using the X-PLOR v.3.1 program (37). The
initial R factor was 28.7% (Rfree = 33.8%) using data from 8 to
4 Å. The model was partitioned into a successively greater
number of groups, 2, 8, 12 and 24, whilst increasing the
resolution to 2.5 Å. After changing to the correct sequence
followed by positional and temperature factor refinement,
R decreased to 30.0% (Rfree = 41.3%) for reflections with Fo >
4σ(Fo) in the range 8–2.5 Å and 35.7% (Rfree = 44.9%) in the
range 8–2.2 Å. An Fo – Fc map at this point clearly showed a
single position for the bromine atom, close to the C5 atom of
cytosine 3: no peak was observed close to cytosine 15 on the
second strand (Fig. 2a). This unequivocally showed that the
DNA duplex is positioned in only one of its two possible orien-
tations in the crystal lattice. Subsequent refinement was con-
ducted with the SHELX-97 program (38), using a standard
library of DNA geometric parameters (39). A total of 78 water
molecules were located in successive Fo– Fc maps. The final R
factor was 20.7% for all data (2756 reflections) in the range 8–
2.3 Å. Rfree was 30.3%.
The TRIBIZ complex was refined, starting with the model as a
rigid body, which gave an initial R factor of 35.9% (Rfree = 43.7%)
with the data from 8 to 4 Å. The model was divided succes-
sively into 2, 8, 12 and 24 groups, increasing the resolution to
the range 8–2.5 Å. At this stage R was 39.9% (Rfree = 50.2%).
The sequence was corrected and 20 water molecules outside
the minor groove were located in a Fo– Fc map. After positional
and temperature factor refinement R was 31.2% (Rfree = 42.9%)
for all data in the range 8–2.3 Å. A subsequent difference map
(Fig. 2b) showed clear density in the minor groove consistent
with the dimensions of the ligand. A significant peak was also
observed close to cytosine 3, adjacent to atom C5. This was
assigned as a bromine atom, again confirming only one orien-
tation for the duplex in the crystal. Subsequent SHELX-97
refinement included the bromine atom and examined both possible
orientations for the ligand. The orientation of the ligand was
not convincingly apparent from the difference map, although
the shape of the density at one end better matched the shape of
the phenol group and its methoxy substituent. After 30 cycles
of refinement both orientations gave the same R value, 28.5%
(for data for 8–2.4 Å). One orientation resulted in an Rfree of
36.1%, with very acceptable density for the ends of the molecule
apparent in the resulting 2Fo – Fc map; however, the other
Figure 1. Benzimidazole drug molecules.
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orientation resulted in an Rfree value of 37.2%, with the density
in the 2Fo – Fc map failing to cover all the terminal atoms of the
ligand. A total of 90 water molecules were subsequently
located in a series of Fo – Fc maps. The water arrangement
around the termini of the TRIBIZ molecule was consistent
with the selected orientation. The final R factor was 20.9 for all
data (2695 reflections) in the range 8–2.3 Å. Rfree was 28.3%.
Final atomic coordinates and structure factors for both struc-
tures have been deposited in the Nucleic Acid Database as
entry numbers BD0011 and DD0014.
a
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RESULTS
DNA structure
The two oligonucleotide structures determined here are at the
same resolution and have been refined by identical procedures,
enabling detailed comparisons to be made between them. The
employment and subsequent location of a single brominated
strand in each structure, as detailed above, has enabled the
possibility of duplex disorder to be decisively rejected.
Minor groove width in these two structures has been
calculated in terms of C4'…C4' inter-strand separations (using
the CURVES program; 40), since C4' rather than P atoms are
directed into the groove and contact the drug molecule. The
native duplex structure is remarkably narrow over most of the
A/T region (Fig. 3a). The narrow region has a minimum width
of 2.5–2.6 Å extending over ~4 bp and is slightly displaced in
the 5' direction. This width is ~0.7 Å less than the comparable
region in the crystal structure of the closely related self-
complementary d(CGCAAATTTGCG)2 duplex (41). In contrast,
the alternating duplex d(CGCATATATGCG) has a minimum
width in the A/T region (again calculated with C4'…C4' distances)
of 3.3 Å (42). Exceptionally narrow minor grooves, of 2.7–2.8 Å,
have also been reported in A-tract crystal structures (32–34),
although the disorder present in some of them may diminish
their accuracy.
The seven central base pair steps in the structure have
marked alternation of local helical twist angles (Fig. 3b). The
TpA step has an exceptionally small value (25º), which is
counterbalanced by high twist values for the ApT steps on
either side, of 45 and 49º (Fig. 3b). The base pairs at the TpA
step are almost entirely unstacked. The twist alternation
extends into the 5'-ATTT region, in contrast to the more even
spread of values in the non-alternating structures (32,33,41).
There is also an unusually small twist value for the TpG step
(of 25º) at the point where the groove is 1.5 Å wider. This
suggests that it is the consequence of the unwound and
unstacked TpA step within the sequence context of overwound
A:T base pairs on either side which results in exceptional groove
narrowing. Values for propeller twist, in contrast, are consist-
ently lower (Fig. 3d) than in other structures with either
Figure 2. (Previous page and above) (a) Base pairs 5BrC3-G22 and C15-G10 in the native structure. Fo – Fc difference density (2.5σ level) is shown in mauve and 2Fo – Fc
(1σ level) in green, after X-PLOR refinement but before the inclusion of the bromine atom or water molecules. (b) 2Fo – Fc difference density map for the TRIBIZ
molecule (1σ level), calculated at the end of the refinement.
b
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alternating or non-alternating A:T base pairs (32–34,41–43). It
appears that, at least in the present structure, narrow groove
width is not directly correlated with propeller twist. The five
central steps in the structure all have negative roll values
(Fig. 3c). The TpA step has a small negative roll, of –2º,
although the total roll over these steps is –12º, which opens up
the major groove and compresses the minor groove and so may
contribute to its narrow width.
An incomplete minor groove pattern of hydration is
observed in this structure, possibly on account of the only
moderate resolution of the structure. The T5-A6 step itself is
fully hydrated, as is the preceding A4-T5 step (Fig. 4a), with in
each case a water molecule bridging between two donor atoms
of the base pair. In the case of the ApT step, the water bridges
O2 thymine atoms as well as to the O4' atom of A6. This water
also contacts two other waters (one of which then bridges
between adenine N3 and thymine O2 of the adjacent TpA
step). The ApT step water molecule is penta-coordinated,
suggesting that it may be a partial occupancy sodium or
potassium ion. The ability of these ‘water’ molecules to bridge
between the two strands is illustrative of the narrowed minor
groove at this point. It is at the centre of a network of six water
molecules, which make a total of three hydrogen bonds to O4'
atoms and five to base edges.
The ligand complex
The TRIBIZ molecule is bound in the minor groove (Fig. 4b),
with the pyrrolidine ring of the drug at the 5'-end of the binding
site, i.e. in the same orientation as in the earlier TRIBIZ complex
(28). The inner facing nitrogen atom on all three benzimidazole
groups each donates a hydrogen bond to a pair of A:T base
pairs (Fig. 5), in bifurcated hydrogen bond arrangements.
Three each are to N3 of adenines and to O2 of thymines. The
TpA step participates in one of these bifurcated interactions.
The six hydrogen bond lengths are all well within accepted
values and the arrangement is closely similar to that in the
TRIBIZ complex with the 5'-AAATTT sequence (28) in the
self-complementary dodecamer d(CGCAAATTTGCG), although
here there are hydrogen bonds to four O2 thymines and only
two to N3 of adenines. The TRIBIZ molecule is thus in an
equivalent position along the sequence in both its complexes.
In both cases the four central A:T base pairs are involved in
this hydrogen bonding network to the drug, with interactions to
both adenines and thymines in the inner-most 2 bp. These 2 bp
are propeller twisted such that the major groove edges of the
adenines approach close together and the N6…N6 separation
is 3.2 Å.
The minor groove width is significantly widened along most
of the A/T stretch, by ~0.8 Å, compared to the native structure
Figure 3. Various helical and base morphology parameters calculated with CURVES (40) for the present native structure and its TRIBIZ complex, for native
d(CGCAAATTTGCG) (41) and for its TRIBIZ (28) and Hoechst 33258 (24) complexes. (a) Minor groove width, calculated using C4' atoms; (b) local helical
twist; (c) local roll; (d) propeller twist.
a b
c d
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(Fig. 3a). The groove dimensions in the ligand complex closely
resemble that of the earlier TRIBIZ complex (28), which
shows a decrease in groove width compared to the native struc-
ture. Thus, regardless of the structural features of the native
sequence, binding of this ligand has induced conformational
change in order to maximise close contacts with the groove
floor and walls. The extent of change in the present structure
on binding TRIBIZ is seen in Figure 3b–d. Thus, the marked
alternation in helical twist angles is no longer apparent and the
tract of negative roll angles becomes slightly positive.
However, the TpA step retains its unstacked feature, as seen in
the native structure. It is remarkable that the six N3 and O2
base edge atoms involved in ligand hydrogen bonding are
preserved in their position since their r.m.s.d. between the
native and ligand complex is only 0.3 Å.
The TRIBIZ molecule is highly twisted along its length
(Table 1), with a total twist of 47º, comparing well with that
found in the self-complementary complex (28), of 41º. This
amount of total twist is required for the ligand to achieve
helical register with all 4 bp in the binding site. It has been
a
b
Figure 4. (a) View into theminor groove of the native structure, in the region around the TpA step, showing the six water molecules situated in the groove. (b) Overall view
of the TRIBIZ complex.
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previously noted (24,45) that the bis-benzimidazole compound
Hoechst 33258 can readily adopt a range of non-planar confor-
mations, dependent on the minor groove environment. Such
conformations are also available in free solution. In this
instance the shape of the groove combines with the positions of
the six hydrogen acceptor atoms to maintain the TRIBIZ
molecule in a highly twisted state.
There are a large number of van der Waals close contacts
between the ligand molecule and the atoms forming the walls
of the minor groove. The majority involve C4' backbone
atoms, although C5' (and very rarely O4' atoms) are sometimes
involved. These contacts are to all benzimidazole subunits,
with closest contacts to the imidazole moieties. The methoxy-
phenyl ring contacts a deoxyribose ring, on strand 2. In contrast,
the pyrrolidine ring at the other end of the ligand is not in close
contact with the walls of the minor groove, which is not at its
narrowest in this region. There are two very close contacts
(2.8 and 3.0 Å) between the inner facing carbon atom of the
pyrrolidine ring and the O2 atoms of the thymines at the 5'-end
ApT step. Their geometries correspond to C-H…O hydrogen
bonds, with near linearity in both instances.
DISCUSSION
We have shown here that a non-self-complementary DNA
sequence containing (an albeit short) hybrid A/T stretch of
alternating and non-alternating A:T base pairs has an excep-
tionally narrow minor groove, which is not confined to the
region immediately around the unstacked TpA step. It may be
premature to generalise this finding to other related A/T
sequences, in view of their flexibility and potential ability to
adopt a variety of B-type polymorphs with varying groove
widths. We can confidently discount any significant role for
crystal packing effects in changing the minor groove width in
the A/T region (46). All of the dodecanucleotide duplexes
discussed and referenced here (and almost all others) crystallise in
the same space group, yet have wide variations in parameters
such as groove width. This is understandable in view of the fact
that the A/T region in these crystal structures is never directly
involved in duplex–duplex intermolecular contacts.
The majority of monomeric DNA minor groove-binding
drugs and ligands have a small binding site, of 3–5 bp. Even so,
they can show a surprising ability to discriminate between
different A/T sequences (16), with Hoechst 33258 showing a
50-fold difference in affinity between the sites 5'-AATT and
5'-TATA. This has been presumed to be likely due to the
presence of the unstacked and unwound TpA steps (Fig. 3a and
b), which would increase minor groove width. It is reasonable
to assume that TRIBIZ, with its greater binding site size, would
have at least as stringent a sequence requirement. The present
structure shows that one such TpA step, embedded in an other-
wise high affinity site, does not have such an effect. On the
contrary, its ability to induce complementary overwinding and
stacking in adjacent steps appears to result in decreased minor
groove width along much of the length of the A/T sequence.
The flexibility of A/T sequences in general means that a
relatively large molecule such as TRIBIZ is able to bind in the
groove, increasing the width appropriately. The energy cost of
Figure 5. Schematic of the DNA–TRIBIZ complex showing the six hydrogen
bonds between benzimidazole subunits and DNA.
Table 1. Torsional twist between benzimidazole subunits in minor groove
complexes
Each torsion angle shown is defined by the four atoms facing into the minor
groove
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the conformational changes required for this are compensated
for upon binding by the large number of van der Waals inter-
actions formed with the hydrophobic atoms lining the groove
walls. An additional contribution to ligand stabilisation arises
from the pair of short C-H…O hydrogen bonds from the pyrro-
lidine group of the ligand, which inter-strand straddles the two
thymine O2 atoms at the 5'-end ApT step. This would not be
possible in the 5'-AAATTT binding site (28) and the pyrrolidine
group in this structure adopts a distinct orientation, with no
hydrogen bonded close contacts to the DNA. Thus, the presence
of the TpA step in the present sequence may confer a modest
amount of additional stabilisation to the TRIBIZ complex.
The relative roles played by the various forces involved in
stabilising minor groove complexes with small molecules continue
to be the subject of debate. In particular, there is controversy
concerning the importance of hydrogen bonding to base edges
compared to van der Waals interactions. Recent calculations of
the absolute free energy of association of netropsin with an A/
T sequence (47) show that, for this drug at least, van der Waals
forces dominate. Binding free energy data on analogues of the
bis-benzimidazole ligand Hoechst 33258 (48) support this
view. The present crystal structure of a TRIBIZ complex
shows a large number of van der Waals contacts between
ligand and DNA, which, numerically at least, greatly outnumber
the (six) base–ligand hydrogen bonds. However, we also
observe conservation of the relative positions of all six hydrogen
bond acceptor atoms on the DNA, comparing the native and
ligand-bound oligonucleotide, in spite of significant structural
changes elsewhere in the structures. This suggests that
although hydrogen bonding is not the dominant force stabilising
the complex, it plays a key steering role in optimally positioning
this ligand in its binding site.
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